Surveillance Alone for Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Preliminary Results
- 1 March 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 131 (3), 491-493
- https://doi.org/10.1016/s0022-5347(17)50461-9
Abstract
A total of 31 men with clinical stage I nonseminomatous germ cell tumors of the testis was followed for 2-18 mo. (median 10 mo.) after inguinal orchiectomy. Of the patients 26 (84%) were continuously free of disease. Relapse occurred in 5 patients (16%) at 2, 2, 4, 4 and 6 mo., respectively, but they were rendered free of disease with combination chemotherapy. The results suggest that careful surveillance following orchiectomy is all that is required for patients who have nonseminomatous germ cell testicular tumors but no obvious regional or visceral metastases.This publication has 11 references indexed in Scilit:
- The treatment of ejaculation disorders after retroperitoneal lymph node dissectionCancer, 1982
- PLACE OF RADICAL NODE DISSECTION IN TESTICULAR TUMOUR THERAPYThe Lancet, 1982
- ORCHIDECTOMY ALONE IN TESTICULAR STAGE I NON-SEMINOMATOUS GERM-CELL TUMOURSThe Lancet, 1982
- Orchidectomy alone for stage I testicular teratoma.BMJ, 1981
- Complications of transabdominal retroperitoneal lymphadenectomyUrology, 1981
- Is semen cryopreservation helpful in testicular cancer?Urology, 1980
- Management of Stages I and II Nonseminomatous Germ Cell Tumors of the TestisCancer, 1980
- Imipramine for aspermia after lymphadenectomyUrology, 1979
- Prognosis for Pathologic Stage I Non-Seminomatous Germ Cell Tumors of the Testis Managed by Retroperitoneal LymphadenectomyJournal of Urology, 1976
- Malignant tumors of the testicle: A review of eighty-three casesThe American Journal of Surgery, 1939